The 6‑month outperformance (+25.6% vs +6.4% for the S&P) is the most compelling signal, suggesting that MRC’s operational execution and pricing power are delivering superior returns even when broader equities lag, reinforcing its attractiveness for investors seeking upside in a stagnant market.
The modest 10‑year annualized return (+1.5%) signals that past acceleration may be waning; if pricing pressure intensifies or acquisition integration stalls, future returns could revert to near‑market levels, eroding the premium investors currently enjoy.
The -3.36% institutional net reduction translates to roughly $150 million of shares sold over the last quarter, which could foreshadow emerging concerns about margin pressure from rising raw material costs; if this trend accelerates, it may erode the current institutional support base.
The 4.1% three‑year CAGR is the most positive signal, demonstrating that even after a steep YoY contraction, MRC has still managed to grow revenue over the longer term, which supports a view that the current dip may be cyclical rather than structural.
The net margin of 1.8% leaves just $18 of profit for every $1,000 of sales; a further 5% revenue drop would push net income below breakeven, highlighting the fragility of profitability under continued market softness.
The most striking finding is the margin swing from -7.3% to +1.8%, which alone accounts for roughly 6.5 percentage points of the 10.7% ROE, underscoring that operational profitability recovery—not leverage—is the engine of shareholder return.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2024 | 10.7 | 1.8 | 1.85 | 3.15 | 12.5 | 12.1 | 3.4 |
| 2023 | 13.5 | 3.3 | 1.81 | 2.24 | 17.3 | 17.0 | 6.0 |
| 2022 | 10.1 | 2.3 | 1.69 | 2.56 | 10.3 | 10.1 | 4.0 |
| 2021 | -2.1 | -0.5 | 1.60 | 2.46 | 0.6 | 0.6 | -0.8 |
| 2020 | -38.9 | -10.7 | 1.44 | 2.53 | -19.1 | -18.8 | -15.4 |
| 2019 | 3.9 | 1.1 | 1.58 | 2.33 | 5.7 | 5.6 | 1.7 |
| 2018 | 7.1 | 1.8 | 1.71 | 2.32 | 6.9 | 6.8 | 3.0 |
| 2017 | 4.5 | 1.4 | 1.56 | 2.10 | 2.6 | 2.6 | 2.1 |
| 2016 | -7.4 | -2.7 | 1.41 | 1.94 | -3.3 | -3.2 | -3.8 |
| 2015 | -25.3 | -7.3 | 1.81 | 1.91 | -13.9 | -13.7 | -13.3 |
A potential risk is the elevated equity multiplier (3.15x); while it boosts ROE now, any increase in interest rates or tightening credit markets could raise debt servicing costs, eroding the current 12.5% ROIC margin and pressuring cash flow.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2024 | 197 | 63 | 46 | 31 | 50 | 59 |
| 2023 | 202 | 75 | 46 | 30 | 48 | 73 |
| 2022 | 216 | 81 | 57 | 32 | 57 | 81 |
| 2021 | 229 | 74 | 52 | 39 | 52 | 73 |
| 2020 | 254 | 87 | 45 | 43 | 45 | 87 |
| 2019 | 232 | 85 | 46 | 32 | 43 | 87 |
| 2018 | 213 | 84 | 51 | 12 | 46 | 89 |
| 2017 | 234 | 84 | 52 | 15 | 49 | 86 |
| 2016 | 260 | 80 | 48 | 16 | 45 | 83 |
| 2015 | 202 | 76 | 43 | 10 | 32 | 87 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2024 | $1624M | $1108M | $516M | $571M | $508M | $63M | $921M | $508M |
| 2023 | $1886M | $1043M | $843M | $521M | $390M | $131M | $1155M | $783M |
| 2022 | $1895M | $1154M | $741M | $558M | $526M | $32M | $1142M | $564M |
| 2021 | $1671M | $993M | $678M | $507M | $459M | $48M | $899M | $436M |
| 2020 | $1781M | $1076M | $705M | $607M | $488M | $119M | $966M | $399M |
| 2019 | $2325M | $1328M | $997M | $752M | $720M | $32M | $1218M | $486M |
| 2018 | $2434M | $1387M | $1047M | $684M | $641M | $43M | $1465M | $569M |
| 2017 | $2340M | $1226M | $1114M | $526M | $478M | $48M | $1318M | $562M |
| 2016 | $2164M | $1046M | $1118M | $414M | $305M | $109M | $1117M | $433M |
| 2015 | $2502M | $1190M | $1311M | $524M | $455M | $69M | $1405M | $444M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2024 | $276M | $-27M | $-314M | $-28M | $248M | $-5M | |
| 2023 | $181M | $-14M | $-67M | $-15M | $166M | $-4M | |
| 2022 | $-20M | $-11M | $17M | $-11M | $-31M | $-2M | |
| 2021 | $56M | $-7M | $-118M | $-10M | $46M | $-4M | |
| 2020 | $261M | $19M | $-195M | $-11M | $250M | $-4M | |
| 2019 | $242M | $-16M | $-238M | $-18M | $224M | $-81M | |
| 2018 | $-11M | $-14M | $24M | $-20M | $-31M | $-130M | |
| 2017 | $-48M | $-27M | $9M | $-30M | $-78M | $-71M | |
| 2016 | $253M | $16M | $-226M | $-33M | $220M | $-95M | |
| 2015 | $690M | $-41M | $-599M | $-39M | $651M | $-12M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net